GlassScriptPhysician profile
Richard William Markus
NPI 1083055214
$291.73
in general payments reported to CMS, 2019-2025
12 companies · $51.80 in 2025
The $51.80 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.92 · 2020: $19.88 · 2021: $11.58 · 2022: $108 · 2023: $37.91 · 2024: $35.98 · 2025: $51.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $69.41 | 2024-2025 | Extended Holter, (Ck7) Extended Holter |
| G Medical Diagnostic Services, INC. | $33.70 | 2020-2022 | |
| Sobi, INC | $26.82 | 2022 | |
| Boston Scientific Corporation | $26.03 | 2022 | |
| Cmp Pharma, INC. | $22.99 | 2022 | |
| Vital Connect, INC | $20.66 | 2023 | Vitalpatch Rtm |
| Ani Pharmaceuticals, INC. | $18.37 | 2024 | Purified Cortrophin Gel |
| Bardy Diagnostics, INC. | $18.00 | 2022 | |
| Baxter Healthcare | $17.25 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $13.68 | 2019 | |
| Braemar Manufacturing, LLC | $13.24 | 2019 | |
| Azurity Pharmaceuticals, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Markus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.